The cornerstone of AdOM, Advanced Optical Technologies Ltd focuses on two areas:   state of the art optical imaging capabilities and leading ophthalmology clinical and research skills . AdOM utilizes its team's vast knowledge in thin film optical imaging technologies to master the spectral imaging domain for the service of clinical ophthalmology. 

The company is currently focused on the commercialization of our state-of-the-art Tear Film Imaging (TFI) device which measures clinically relevant parameters of the tear film dynamics with the potential to enhance the management of dry eye disease. 


More than 30 different patent applications have been filed for the AdOM technology, of which twenty-one (21) were granted both in Israel, the US and the EU. This cutting-edge technology has been published by several peer reviewed scientific journals.